Adeshwar Meditex corrects RPT figures reported to BSE

2 min read     Updated on 22 May 2026, 10:00 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Adeshwar Meditex Limited corrected typographical errors in related party transaction figures reported to the BSE on May 22, 2026. The revisions updated salary and interest amounts for five individuals, including Mr. K Nagarajarao and Mr. Abhinandan N. The company provided a full revised schedule of transactions involving directors and KMPs.

powered bylight_fuzz_icon
41013022

*this image is generated using AI for illustrative purposes only.

Adeshwar Meditex Limited has submitted a clarification to the Bombay Stock Exchange regarding a typographical error in its related party transaction disclosures. The notification, dated May 22, 2026, corrects figures initially reported following the board meeting held on May 21, 2026.

The company identified errors in Annexure III of the previous filing, specifically concerning the remuneration and interest amounts for certain Key Managerial Personnel (KMP). The revised amounts rectify the inadvertent mistakes in the initial submission.

Corrections to Transaction Amounts

The following specific amounts were corrected in the filing:

  • Interest on a loan with Mr. Abhinandan Rao is revised to 10.78 Lakhs from 1.18 Lakhs.
  • Salary of Mr. Shailesh Rajpure is revised to 12.60 Lakhs from 12.00 Lakhs.
  • Salary of Mr. K Nagarajarao is revised to 87.00 Lakhs from 84.00 Lakhs.
  • Salary of Mr. Abhinandan N is revised to 39.00 Lakhs from 36.00 Lakhs.
  • Salary of Mrs. Ashalata B Raut is revised to 38.75 Lakhs from 36.00 Lakhs.

Revised Related Party Transactions

The company provided the complete revised schedule of related party transactions. The table below details the nature and amounts of these transactions as per the corrected filing.

Name of the related party Relationship Type of transaction Amount of transaction (in Lakhs)
Mr. K Nagarajarao Director - KMP Salary 87.00
Mr. K Nagarajarao Director - KMP Loan Taken from Director 150.00
Mr. K Nagarajarao Director - KMP Interest Paid 13.50
Mr. Abhinandan N Director - KMP Salary 39.00
Mr. Abhinandan N Director - KMP Loan Taken from Director 160.00
Mr. Abhinandan N Director - KMP Interest Paid 10.78
Mrs. Ashalata B. Raut Director - KMP Salary 38.75
Mrs. Ashalata B. Raut Director - KMP Loan taken from Director 15.00
Mrs. Ashalata B. Raut Director - KMP Interest Paid 1.18
Mr. Shailesh Rajpure Director - KMP Salary 12.60
M/s Moksha Biosurgicals Pvt Ltd Associates / Enterprises with significant influence Purchase & Labour Charges 0.00
M/s Moksha Biosurgicals Pvt Ltd Associates / Enterprises with significant influence Rent paid 7.80
M/s Shivadesh Meditex Director is Proprietor Purchase & Labour Charges 0.16
M/s Shivadesh Meditex Director is Proprietor Sales 111.56
Mr. Prashant Rane Chief Financial Officer Salary 6.00
Mr. Vishal Jain Compliance Officer Salary 3.60
Mr. Arun Shankar Koli Independent Director Director Seating Fees 0.00
Mr. Benegal Parameshwara Udpa Independent Director Director Seating Fees 0.00
Mr. Prithvi Sanjay Singh Additional Non-Executive Director Director Seating Fees 0.00

The clarification was signed by Krishnojirao Nagaraja Rao, Director of adeshwar meditex , on May 22, 2026.

Will SEBI or BSE initiate a scrutiny process into Adeshwar Meditex's internal financial controls following this typographical correction in related party disclosures?

How might the significant loans taken from directors (totaling ₹325 Lakhs) impact Adeshwar Meditex's debt structure and future fundraising capabilities?

Could the pattern of KMP salary revisions raise concerns among minority shareholders about corporate governance standards at Adeshwar Meditex during upcoming annual general meetings?

Adeshwar Meditex FY26 net profit at Rs 126.49 lakh

1 min read     Updated on 21 May 2026, 01:44 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Adeshwar Meditex announced its audited financial results for the year ended March 31, 2026, reporting a net profit of Rs 126.49 lakh on revenue of Rs 5,610.38 lakh. The board approved the appointment of Ms. Bhagyalaxmi Kavital as an Additional Independent Director and discussed fund raising plans of up to Rs 40 Crores. The trading window closure will end 48 hours post-results announcement.

powered bylight_fuzz_icon
40325765

*this image is generated using AI for illustrative purposes only.

adeshwar meditex has announced the outcome of its board meeting held on May 21, 2026. The board approved the audited financial results for the half year and financial year ended March 31, 2026. The statutory auditors issued an unmodified opinion on the results.

Financial Performance

For the financial year ended March 31, 2026, the company reported a net profit of Rs 126.49 lakh, a decrease from Rs 206.57 lakh in the previous year. Revenue from operations stood at Rs 5,610.38 lakh, down from Rs 8,371.31 lakh in FY25. Total income for the year was Rs 5,620.76 lakh.

For the half year ended March 31, 2026, the net profit was Rs 53.38 lakh on a total income of Rs 2,609.77 lakh.

Particulars Year Ended 31.03.2026 (Audited) Year Ended 31.03.2025 (Audited)
Revenue From Operations 5,610.38 8,371.31
Total Income 5,620.76 8,397.17
Total Expenses 5,437.57 8,117.83
Net Profit 126.49 206.57

Board Decisions

In addition to the financial results, the board took note of the resignation of Mr. Arun Koli from the post of Independent Director. The board approved the appointment of Ms. Bhagyalaxmi Kavital as an Additional (Non-Executive) Independent Director. The directors also discussed raising funds up to Rs 40 Crores by way of further issue of Equity shares and the acceptance of director's loans or borrowing funds in the form of debentures.

Compliance and Trading Window

The trading window for the company's securities, which was closed since April 1, 2026, will reopen 48 hours after the announcement of the financial results. The intimation regarding the board meeting was submitted to BSE Limited in compliance with Regulation 29 and 33 of the SEBI (LODR) Regulations, 2015.

How does Adeshwar Meditex plan to deploy the Rs 40 crore raised through equity issuance to reverse the significant revenue decline from FY25 to FY26?

What strategic initiatives is Adeshwar Meditex considering to recover the ~33% drop in revenue from operations and restore profitability to FY25 levels?

How might the appointment of Ms. Bhagyalaxmi Kavital as Independent Director influence the company's governance and fundraising strategy going forward?

More News on Adeshwar Meditex